Cash from Operations (TTM) Chart

Historical Cash from Operations (TTM) Data

View and export this data back to 2013. Upgrade now.
Date Value
December 31, 2023 -119.38M
September 30, 2023 -128.50M
June 30, 2023 -124.73M
March 31, 2023 -114.43M
December 31, 2022 -110.62M
September 30, 2022 -107.42M
June 30, 2022 -120.71M
March 31, 2022 -115.02M
December 31, 2021 -102.45M
September 30, 2021 -50.59M
June 30, 2021 -27.64M
March 31, 2021 -23.21M
December 31, 2020 -22.16M
September 30, 2020 -39.57M
June 30, 2020 -45.98M
March 31, 2020 -35.59M
December 31, 2019 -32.53M
September 30, 2019 53.32M
June 30, 2019 55.20M
March 31, 2019 51.68M
December 31, 2018 58.38M
Date Value
September 30, 2018 -33.60M
June 30, 2018 -32.64M
March 31, 2018 -29.73M
December 31, 2017 -28.93M
September 30, 2017 -31.36M
June 30, 2017 -30.77M
March 31, 2017 -33.87M
December 31, 2016 -35.56M
September 30, 2016 -32.94M
June 30, 2016 -31.08M
March 31, 2016 -25.53M
December 31, 2015 -20.57M
September 30, 2015 -23.41M
June 30, 2015 -17.90M
March 31, 2015 -19.71M
December 31, 2014 -14.03M
September 30, 2014 -9.784M
June 30, 2014 -4.261M
March 31, 2014 -3.316M
December 31, 2013 -7.541M

Cash From Operations Definition

Cash flow from operations is a major line item of the statement of cash flows. This metric tracks the movement of cash flows for the overall operating activities of the company. A few examples of operating activities include change in receivables, change in inventories, and changes in current assets.

Read full definition.

Cash from Operations (TTM) Range, Past 5 Years

-128.50M
Minimum
Sep 2023
55.20M
Maximum
Jun 2019
-63.79M
Average
-50.59M
Median
Sep 2021

Cash from Operations (TTM) Benchmarks

InflaRx NV -40.94M
MorphoSys AG --
BioNTech SE 5.815B
Immatics NV 19.73M
CureVac NV -307.16M